Immunohistochemistry: Unveiling the Molecular Landscape of Tissues

Immunohistochemistry (IHC) is a widely used technique in pathology that combines histological, immunological, and biochemical methods to visualize and locate specific molecules, such as proteins, within tissue sections. This technique has a Vibe score of 80, reflecting its significant cultural energy in the scientific community. Developed in the 1940s by Albert Coons, IHC has become a cornerstone in diagnostic pathology, enabling the identification of specific cell types, detection of infectious agents, and diagnosis of various diseases, including cancer. With over 10,000 publications annually, IHC is a highly influential field, with key contributors including the National Institutes of Health (NIH) and the World Health Organization (WHO). The controversy spectrum for IHC is moderate, with debates surrounding the interpretation of results and the need for standardized protocols. As research continues to advance, IHC is likely to remain a vital tool in the pursuit of understanding human disease, with potential applications in personalized medicine and targeted therapies. By 2025, the global IHC market is expected to reach $2.5 billion, driven by increasing demand for diagnostic testing and research applications.